Cargando…
Relaxin as a natural agent for vascular health
Hypertension, atherothrombosis, myocardial infarction, stroke, peripheral vascular disease, and renal failure are the main manifestations of cardiovascular disease (CVD), the leading cause of death and disability in developed countries. Continuing insight into the pathophysiology of CVD can allow id...
Autor principal: | Bani, Daniele |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515412/ https://www.ncbi.nlm.nih.gov/pubmed/18827902 |
Ejemplares similares
-
Relaxin receptors and nitric oxide synthases: search for the missing link
por: Nistri, Silvia, et al.
Publicado: (2003) -
Relaxin
por: DeCherney, Alan H.
Publicado: (1982) -
Protection from cigarette smoke‐induced vascular injury by recombinant human relaxin‐2 (serelaxin)
por: Pini, Alessandro, et al.
Publicado: (2016) -
Synthetic short-chain peptide analogues of H1 relaxin lack affinity for the RXFP1 receptor and relaxin-like bioactivity. Clues to a better understanding of relaxin agonist design
por: D'Ercole, Annunziata, et al.
Publicado: (2022) -
Relaxin'
Publicado: (1983)